Mouse β3a- and β3b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signalling pathways

被引:55
作者
Hutchinson, DS
Bengtsson, T
Evans, BA
Summers, RJ
机构
[1] Monash Univ, Dept Pharmacol, Clayton, Vic 3800, Australia
[2] Univ Stockholm, Arrhenius Labs F3, Wenner Gren Inst, SE-10691 Stockholm, Sweden
关键词
beta(3)-adrenoceptor; splice variant; cytosensor microphysiometer; Erk1/2; cyclic AMP; mouse;
D O I
10.1038/sj.bjp.0704654
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 This study characterizes the mouse beta(3a)-adrenoceptor (AR) and the splice variant of the beta(3)-AR (beta(3b)-AR) expressed in Chinese hamster ovary cells (CHO-K1). 2 Stable clones with high (similar to 1200), medium (similar to 500) or low receptor expression (similar to 100 fmol mg protein(-1)) were determined by saturation binding with [I-125]-(-)-cyanopindolol. Competition binding studies showed no significant differences in affinity of beta-AR ligands for either receptor. 3 Several functional responses of each receptor were measured, namely extracellular acidification rate (EAR; cytosensor microphysiometer), cyclic AMP accumulation, and Erk1/2 phosphorylation. The beta(3)-AR agonists BRL37344, CL316243, GR265162X, L755507, SB251023, the non-conventional partial beta-AR agonist CGP12177 and the beta-AR agonist (-)-isoprenaline caused concentration-dependent increases in EAR in cells expressing either splice variant. CL316243 caused concentration-dependent increases in cyclic AMP accumulation and Erk1/2 phosphorylation in cells expressing either receptor. 4 PTX treatment increased maximum EAR and cyclic AMP responses to CL316243 in cells expressing the beta(3b)-AR but not in cells expressing the beta(3a)-AR at all levels of receptor expression. 5 CL316243 increased Erk1/2 phosphorylation with pEC(50) values and maximum responses that were not significantly different in cells expressing either splice variant. Erk1/2 phosphorylation was insensitive to PTX or H89 (PKA inhibitor) but was inhibited by LY294002 (P13Kgamma inhibitor), PP2 (c-Src inhibitor), genistein (tyrosine kinase inhibitor) and PD98059 (MEK inhibitor). 6 The adenylate cyclase activators forskolin or cholera toxin failed to increase Erk-1/2 levels although both treatments markedly increased cyclic AMP accumulation in both beta(3a)- or beta(3b)-AR transfected cells. 7 These results suggest that in CHO-K1 cells, the beta(3b)-AR, can couple to both G(s) and G(i) to stimulate and inhibit cyclic AMP production respectively, while the beta(3a)-AR, couples solely to G(s) to increase cyclic AMP levels. However, the increase in Erk1/2 phosphorylation following receptor activation is not dependent upon coupling of the receptors to G(i) or the generation of cyclic AMP.
引用
收藏
页码:1903 / 1914
页数:12
相关论文
共 39 条
[1]   MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3-kinase but not the cAMP/PKA pathway [J].
Ai, WD ;
Gong, JH ;
Yu, L .
FEBS LETTERS, 1999, 456 (01) :196-200
[2]   A kinase-regulated PDZ-domain interaction controls endocytic sorting of the β2-adrenergic receptor [J].
Cao, TT ;
Deacon, HW ;
Reczek, D ;
Bretscher, A ;
von Zastrow, M .
NATURE, 1999, 401 (6750) :286-290
[3]   Direct binding of activated c-Src to the β3-adrenergic receptor is required for MAP kinase activation [J].
Cao, WH ;
Luttrell, LM ;
Medvedev, AV ;
Pierce, KL ;
Daniel, KW ;
Dixon, TM ;
Lefkowitz, RJ ;
Collins, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (49) :38131-38134
[4]   Molecular cloning, genomic characterization and expression of novel human α1A-adrenoceptor isoforms [J].
Chang, DJ ;
Chang, TK ;
Yamanishi, SS ;
Salazar, FHR ;
Kosaka, AH ;
Khare, R ;
Bhakta, S ;
Jasper, JR ;
Shieh, IS ;
Lesnick, JD ;
Ford, APDW ;
Daniels, DV ;
Eglen, RM ;
Clarke, DE ;
Bach, C ;
Chan, HW .
FEBS LETTERS, 1998, 422 (02) :279-283
[5]   DIFFERENTIAL INTERACTION OF BETA(1)-ADRENERGIC AND BETA(3)-ADRENERGIC RECEPTORS WITH G(I) IN RAT ADIPOCYTES [J].
CHAUDHRY, A ;
MACKENZIE, RG ;
GEORGIC, LM ;
GRANNEMAN, JG .
CELLULAR SIGNALLING, 1994, 6 (04) :457-465
[6]   Influence of receptor number on functional responses elicited by agonists acting at the human adenosine A1 receptor:: Evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity [J].
Cordeaux, Y ;
Briddon, SJ ;
Megson, AE ;
McDonnell, J ;
Dickenson, JM ;
Hill, SJ .
MOLECULAR PHARMACOLOGY, 2000, 58 (05) :1075-1084
[7]  
EASON MG, 1992, J BIOL CHEM, V267, P15795
[8]   Alternative splicing generates two isoforms of the β3-adrenoceptor which are differentially expressed in mouse tissues [J].
Evans, BA ;
Papaioannou, M ;
Hamilton, S ;
Summers, RJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (06) :1525-1531
[9]   THE 5-HT4 RECEPTOR - MOLECULAR-CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF 2 SPLICE VARIANTS [J].
GERALD, C ;
ADHAM, N ;
KAO, HT ;
OLSEN, MA ;
LAZ, TM ;
SCHECHTER, LE ;
BARD, JA ;
VAYSSE, PJJ ;
HARTIG, PR ;
BRANCHEK, TA ;
WEINSHANK, RL .
EMBO JOURNAL, 1995, 14 (12) :2806-2815
[10]   Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human beta-3 adrenergic receptor:: New pharmacological profile and mechanism of activation [J].
Gerhardt, CC ;
Gros, J ;
Strosberg, AD ;
Issad, T .
MOLECULAR PHARMACOLOGY, 1999, 55 (02) :255-262